Form 10 Explorer
10-K
Annual Report
ACRO BIOMEDICAL CO., LTD.

CIK: 1622996

File #: 000-55643

Period End: Dec 31, 2024

Fiscal Year: 2024

View on EDGAR
Balance Sheet
31 line items · 2 periods
XBRL
ItemDec 31, 2024Dec 31, 2023
Balance Sheets
ASSETS
Current Assets
Cash
476376
Other Non-Operating Current Assets
01,250
Security deposit
4,6000
Total Current Assets
5,0761,626
Operating Lease Right-of-Use Asset
26,89852,233
Security deposit
04,600
TOTAL ASSETS
31,97458,459
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities
Accounts Payable
154,460154,444
Other Current Liabilities
20,00020,000
Due to related parties
125,58888,796
Operating Lease Liability, Current
26,89825,335
Total Current Liabilities
326,946288,575
Operating Lease Liability, Non-Current
026,898
TOTAL LIABILITIES
326,946315,473
Stockholders' Deficit
Preferred Stock
00
Total Stockholders' Equity
60,04260,042
Total Stockholders' Equity
32,302,78132,298,442
Total Stockholders' Equity
(32,657,795)(32,615,498)
Total Stockholders' Deficit
(294,972)(257,014)
Accumulated Deficit
(32,657,795)(32,615,498)
Deferred stock compensation
00
Additional Paid-In Capital
32,302,78132,298,442
Common Stock
60,04260,042
Preferred Stock
00
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
31,97458,459
ACRO BIOMEDICAL CO., LTD. — 10-K Filing | Form 10 Explorer